Valiant Organics Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹304 Cr +93.6% YoYSee revenue, profit and what management said. You are viewing Q4 FY26.
VO

Valiant Organics Ltd

Q4 FY26Chemicals & Petrochemicals

Valiant Organics Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 investor presentation: what the company reported on revenue, margins and capex.

Revenue
₹218Cr
+6.9% YoY
+37.1% QoQ
Net profit
₹16Cr
+300% YoY
+300% QoQ
Margin
12%
+2 pp YoY
+4 pp QoQ

Based on Valiant Organics Ltd's Q4 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹411
Market cap₹1.2K Cr
P/E23.7

The short version

Q4-FY26 Consolidated Revenue from Operations: INR 2,178 million, up 6.9% year-on-year from INR 2,038 million in Q4-FY25 (Page 12). Quarterly Q4-FY26 (Standalone) Financials: - EBITDA: INR 265 Mn (↑ 30.5% YoY from INR 203 Mn) - EBITDA Margin: 12.17% (↑ 221 bps YoY from 9.96%) - Profit After Tax (PAT): INR 151 Mn (↑ signifi

From Valiant Organics Ltd's Q4 FY26 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

  • Q4-FY26 Consolidated Revenue from Operations: INR 2,178 million, up 6.9% year-on-year from INR 2,038 million in Q4-FY25 (Page 12).
  • Q4-FY26 Standalone Revenue from Operations: INR 2,177 million, up 6.8% year-on-year from INR 2,038 million in Q4-FY25 (Page 14).
  • Sales Volumes by Chemistry (Q4-FY26 vs. Q4-FY25):
  • Chlorination: approx. 413 MT vs. 362 MT
  • Hydrogenation: approx. 1,050 MT vs. 672 MT

2 more points from Valiant Organics Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Valiant Organics Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Key manufacturing capacities at existing plants as of the presentation are noted: - Chlorination (Sarigam): 18,000 MTPA - Ammonolysis (Vapi): 10,000 MTPA - Ammonolysis (Tarapur): 6,600 MTPA - Hydrogenation & Methoxylation (Jhagadia Unit 1): 28,800 MTPA

2 more points from Valiant Organics Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
2Shiv Texchem
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Valiant Organics Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Valiant Organics Ltd said on order book & pipeline — free account, 30 seconds.

Valiant Organics Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Valiant Organics Ltd Q4 FY26 results — key figures

Valiant Organics Ltd Q4 FY26 reported results vs Q4 FY25, ₹ crore
₹ CrQ4 FY26Q4 FY25YoYQ3 FY26QoQ
Revenue218204+6.9%159+37.1%
Operating profit (EBITDA)2621+23.8%13+100%
Operating margin12%10%+2 pp8%+4 pp
Profit before tax187+157.1%6+200%
Net profit (PAT)164+300%4+300%
EPS (₹)5.611.50+274%1.30+331.5%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹304 Cr, net profit ₹17 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Indian Phosphate (Q4 FY26)

    H2 FY26 Revenue (Consolidated):** ₹580.25 Cr, up from ₹451.59 Cr in H2 FY25 — a year-on-year increase of ₹128.66 Cr. Key investor presentation takeaways from In

  • Paragon Fine (Q4 FY26)

    Revenue for H2FY26:** Rs 68.88 Cr, up 7.41% YoY from Rs 64.13 Cr in H2FY25 (Page 22). Key investor presentation takeaways from Paragon Fine's Q4 FY26 investor p

  • IVP (Q4 FY26)

    Q4 FY26 revenue from operations: ₹164.44 crore . Key investor presentation takeaways from IVP's Q4 FY26 investor presentation — and how it ranks against sector

  • Vishnu Chemicals (Q4 FY26)

    Q4 FY26 Operating Revenues: ₹450.3 crore, up 14.7% YoY from ₹392.6 crore in Q4 FY25 (Page 5). Key investor presentation takeaways from Vishnu Chemicals Ltd's Q4

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Valiant Organics Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Valiant Organics Ltd Q4 FY26 results?

Q4-FY26 Consolidated Revenue from Operations: INR 2,178 million, up 6.9% year-on-year from INR 2,038 million in Q4-FY25 (Page 12). Quarterly Q4-FY26 (Standalone) Financials: - EBITDA: INR 265 Mn (↑ 30.5% YoY from INR 203 Mn) - EBITDA Margin: 12.17% (↑ 221 bps YoY from 9.96%) - Profit After Tax (PAT): INR 151 Mn (↑ signifi

What is Valiant Organics Ltd share price analysis?

Valiant Organics Ltd currently shows a neutral. The stock trades at a P/E of 23.7 with a market cap of ₹1,196 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Valiant Organics Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.